Patent Assignment
Reel/Frame 053767/0445
RELEASE OF SECURITY INTEREST
Recorded: 2020-09-14
Received: 2020-09-14
Pages: 137
Assignor
BIOPHARMA CREDIT PLC
Executed: 2020-09-08
Assignee
LEXICON PHARMACEUTICALS, INC.
8800 TECHNOLOGY FOREST PLACE, THE WOODLANDS, TX, 77381, UNITED STATES
Covered Applications
(100)
SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE
App. No. 15/155,780
→
INHIBITORS OF SODIUM GLUCOSE COTRANSPORTER 1
App. No. 14/943,505
→
INHIBITORS OF ADAPTER ASSOCIATED KINASE 1, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 14/658,653
→
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 14/483,898
→
4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE
App. No. 14/284,106
→
INHIBITORS OF SODIUM GLUCOSE COTRANSPORTER 1
App. No. 14/082,786
→
SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE
App. No. 13/925,981
→
MST1 KINASE INHIBITORS AND METHODS OF THEIR USE
App. No. 13/886,351
→
METHODS FOR TREATING PULMONARY HYPERTENSION
App. No. 13/845,533
→
PYRAZOLO[1,5-A]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 13/785,355
→
IMIDAZO[1,2-B]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 13/785,271
→
Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
App. No. 13/505,895
→
METHODS OF PREPARING 1-(4-((1R,2S,3R)-1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL)ETHANONE
App. No. 13/597,509
→
METHODS OF TREATING DIABETES
App. No. 13/530,645
→
SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE
App. No. 13/486,103
→
LIMK2 INHIBITORS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 13/486,122
→
MST1 KINASE INHIBITORS AND METHODS OF THEIR USE
App. No. 13/410,407
→
METHODS OF TREATING ULCERATIVE COLITIS
App. No. 13/343,073
→
MONOCLONAL ANTIBODIES AGAINST ANGPTL4
App. No. 13/315,027
→
TRYPTOPHAN HYDROXYLASE INHIBITORS
App. No. 13/290,261
→
SOLID FORMS OF (S)-2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOIC ACID
App. No. 13/288,366
→
SOLID FORMS OF 3-(4-(AMINOMETHYL)-1-(5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDO)PHENYL DIMETHYLCARBAMATE
App. No. 13/288,321
→
METHODS AND COMPOUNDS USEFUL FOR THE PREPARATION OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS
App. No. 13/207,576
→
4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds and Methods of Their Use
App. No. 13/162,989
→
METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS
App. No. 13/160,678
→
MONOCLONAL ANTIBODIES AGAINST ANGPTL3
App. No. 13/073,617
→
MST1 KINASE INHIBITORS AND METHODS OF THEIR USE
App. No. 61/449,171
→
COMPOUNDS USEFUL IN THE PREPARATION OF TRYPTOPHAN HYDRROXYLASE INHIBITORS
App. No. 13/024,469
→
METHODS OF TREATING PULMONARY HYPERTENSION
App. No. 13/006,592
→
PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLALANINES
App. No. 12/948,901
→
METHODS OF TREATING ULCERATIVE COLITIS
App. No. 12/911,011
→
METHODS OF PREPARING 1-(4-((1R,2S,3R)-1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL)ETHANONE
App. No. 12/911,172
→
METHODS OF TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES AND DISORDERS
App. No. 12/903,657
→
MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88
App. No. 12/898,016
→
MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88
App. No. 12/897,004
→
MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88
App. No. 12/895,916
→
METHODS OF PREPARING IMIDAZOLE-BASED COMPOUNDS
App. No. 12/885,738
→
SULFANYL-TETRAHYDROPYRAN-BASED COMPOUNDS AND METHODS OF THEIR USE
App. No. 12/858,666
→
METHODS OF USING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS
App. No. 12/754,341
→
METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN
App. No. 12/754,284
→
MULTICYCLIC AMINO ACID DERIVATIVES AND METHODS OF THEIR USE
App. No. 12/750,278
→
1-PHENYL-1H-PYRAZOLE-BASED COMPOUNDS
App. No. 12/732,311
→
TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER
App. No. 61/303,395
→
MULTICYCLIC COMPOUNDS AND METHODS OF THEIR USE
App. No. 12/633,453
→
MONOCLONAL ANTIBODIES AGAINST ANGPTL4
App. No. 12/631,598
→
METHODS OF TREATING RHEUMATOID ARTHRITIS
App. No. 12/628,309
→
PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLALANINES
App. No. 61/262,834
→
TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER
App. No. 61/258,476
→
METHODS OF PREPARING 1-(4-((1R,2S,3R)-1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL)ETHANONE
App. No. 61/254,960
→
HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE
App. No. 12/545,954
→
COMBINATIONS COMPRISING BICYCLIC S1P LYASE INHIBITORS
App. No. 12/544,504
→
(E)-1-(4-((1R,2S,3R)-1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL)ETHANONE OXIME DIHYDRATE AND METHODS OF ITS USE
App. No. 12/536,714
→
SOLID FORMS OF (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS OF THEIR USE
App. No. 12/503,225
→
SOLID FORMS OF (1R,2S,3R)-1-(2-(ISOXAZOL-3-YL)-1H-IMIDAZOL-4-YL)BUTANE-1,2,3,4-TETRAOL AND METHODS OF THEIR USE
App. No. 12/485,444
→
METHODS OF PREPARING IMIDAZOLE-BASED BICYCLIC COMPOUNDS
App. No. 12/485,507
→
METHODS OF TREATING SCHIZOPHRENIA
App. No. 12/484,337
→
4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE
App. No. 12/468,974
→
(R)-PHENYL(HETEROCYCLE)METHANOL-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE
App. No. 12/468,176
→
LIMK2 INHIBITORS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 12/426,661
→
(S)-(3'_CHLOROBIPHENYL-4-YL)(1-(PYRIMIDIN-2-YL) PIPERIDIN-4-YL) METHANOL AND COMPOSTITIONS COMPRISING THE SAME
App. No. 12/409,640
→
4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds For The Treatment Of Osteoporosis
App. No. 61/118,764
→
Compositions and Methods For Treating Osteoporosis
App. No. 61/118,521
→
Bicyclic S1P Lyase Inhibitors For The Treatment Of Cerebral Malaria
App. No. 61/109,987
→
PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLALANINES
App. No. 12/257,558
→
SOLID FORMS OF (S)-2-AMINO-3-(4-(2-AMINO-6-((R)-2,2,2-TRIFLUORO-1-(3'-METHOXYBIPHENYL-4-YL)ETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOIC ACID AND METHODS OF THEIR USE
App. No. 12/246,735
→
SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE
App. No. 12/237,455
→
COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL AND INFLAMMATORY DISEASES AND DISORDERS
App. No. 12/204,918
→
METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS
App. No. 12/196,341
→
Combinations Comprising Bicyclic S1P Lyase Inhibitors
App. No. 61/090,963
→
SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES AS LIM KINASE 2 INHIBITORS
App. No. 12/188,515
→
METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN
App. No. 12/174,741
→
METHODS AND COMPOUNDS USEFUL FOR THE PREPARATION OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS
App. No. 12/174,722
→
METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION AND RELATED DISEASES AND DISORDERS
App. No. 12/169,815
→
PARTICULATE (3'-CHLOROBIPHENYL-4-YL)(1-(PYRIMIDIN-2-YL)PIPERIDIN-4-YL)METHANONE AND METHODS OF ITS USE
App. No. 12/147,589
→
METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS
App. No. 12/144,821
→
Solid Forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime
App. No. 12/101,445
→
METHODS OF PREPARING IMIDAZOLE-BASED COMPOUNDS
App. No. 12/101,410
→
Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same
App. No. 12/099,465
→
Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same
App. No. 12/099,459
→
Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same
App. No. 12/057,851
→
PIPERDINE-BASED INHIBITORS OF SODIUM GLUCOSE CO-TRANSPORTER 2 AND METHODS OF THEIR USE
App. No. 12/041,860
→
HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE
App. No. 12/038,872
→
Methods and compositions for the treatment of pain, inflammation and cancer
App. No. 12/015,714
→
Methods and compositions for the treatment of body composition disorders
App. No. 12/015,728
→
O-LINKED PYRIMIDIN-4-AMINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE TO TREAT CANCER
App. No. 11/954,433
→
4-AMINO-1H-PYRIMIDIN-2-ONE BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE
App. No. 11/954,421
→
4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE
App. No. 11/954,000
→
MONOCLONAL ANTIBODIES AGAINST ANGPTL3
App. No. 12/001,012
→
Methods of Treating Cognitive Impairment and Dementia
App. No. 11/935,081
→
(R)-PHENYL(HETEROCYCLE)METHANOL-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE
App. No. 11/935,051
→
(S)-PHENYL(HETEROCYCLE)METHANOL-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE
App. No. 11/935,040
→
Amine-linked Multicyclic Compounds and Methods of Their Use
App. No. 11/935,011
→
Genetically engineered and phenotyped mice and stem cell clones for producing the same
App. No. 11/978,234
→
PROCESS FOR PREPARING 5-ALKYL-7H-PYRROLO[2,3-D] PYRIMINDINE-2-OLS
App. No. 11/876,051
→
SOLID FORMS OF (S)-2-AMINO-3-(4-(2-AMINO-6-((R)-2,2,2-TRIFLUORO-1-(3'-METHOXYBIPHENYL-4-YL)ETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOIC ACID AND METHODS OF THEIR USE
App. No. 60/978,303
→
INHIBITORS OF SODIUM GLUCOSE CO-TRANSPORTER 2 AND METHODS OF THEIR USE
App. No. 11/862,690
→
COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL AND INFLAMMATORY DISEASES AND DISORDERS
App. No. 60/970,416
→
KINASE INHIBITORS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
App. No. 60/954,698
→
SYNTHESIS OF PIPERAZINES, PIPERIDINES AND RELATED COMPOUNDS
App. No. 11/832,738
→
SOLID FORMS OF (3'-CHLOROBIPHENYL-4-YL)(1-(PYRIMIDIN-2-YL)PIPERIDIN-4-YL)METHANONE AND METHODS OF THEIR USE
App. No. 11/832,728
→